Table 2.
Themes | Reasons for use by people with cancer | Frequency n (%) | Approved indications | Examples |
---|---|---|---|---|
Limiting the impacts of cancer and its side effects | Managing refractory nausea and vomiting | 130/163 (79.8%) | √ |
•Reduce the frequency and severity of nausea •Treat anticipatory nausea and vomiting •Use with highly or moderately emetogenic chemotherapy •Manage nausea associated with radiotherapy •Limit delayed emesis |
Complementary use to assist in pain management | 120/163 (73.6%) | √ |
•Relieve cancer-associated pain •Treat neuropathic pain •Adjuvant for cancer pain not completely relieved by opioid therapy •Use when refractory to opioids and conventional pain management techniques •Enhance the anti-nociceptive effect of morphine |
|
Improving appetite and food intake | 88/163 (54%) | √ |
•Increase food enjoyment •Weight gain/stabilization •Limit anorexia and cachexia syndrome •Improve taste and smell |
|
Helping to manage emotions | 59/163 (36.2%) |
•Reduce stress •Improve mood •Treat anxiety •Use to cope emotionally •Allow relief of psychological symptoms |
||
Promoting sleep and reducing insomnia | 56/163 (34.4%) |
•Improve sleep quality •Facilitate sleep •Reinforce sleep habit •Reduce sleep disruptions |
||
Easily perform activities of daily living and domestic activities | 23/163 (14.1%) |
•Boost energy and reduce fatigue •Facilitate daytime activities •Improve concentration and memory •Increase activity tolerance |
||
Alleviating musculoskeletal symptoms | 10/163 (6.1%) |
•Combat muscle tension •Reduce spasticity •Treat arthritis •Decrease spasm and tremors •Control trismus |
||
Managing respiratory symptoms | 3/163 (1.8%) | •Reduce dyspnea, shortness of breath and coughs | ||
Staying connected to others | Recreational use | 11/163 (6.7%) | •Enjoyment | |
Improving sexual function and libido | 5/163 (3.1%) | •Increase frequency of sexual intercourses | ||
Stimulating social interactions | 3/163 (1.8%) |
•Enhance social interactions •Feel part of a group |